# China Venture Capital

The Neuralink Dream vs. The EEG Reality: Neuracle’s Bid to Become China’s First BCI Stock

Neuracle Technology is seeking a landmark IPO on Shanghai's STAR Market, leveraging its status as a pioneer in invasive brain-computer interfaces. However, the company remains unprofitable and currently relies almost entirely on sales of traditional EEG machines, as its frontier BCI technology faces a long and uncertain path to commercialization.